Open AccessCoronary Artery Disease and Coronary Artery Bypass Grafting at the Time of Lung Transplantation Do Not Impact Overall Survival
Author(s) -
K. Halloran,
A. Hirji,
David Li,
K. Jackson,
A. Kapasi,
Steve Meyer,
John C. Mullen,
Dale Lien,
J. Weinkauf
Publication year - 2019
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000002609
Subject(s) - medicine , coronary artery disease , perioperative , lung transplantation , revascularization , intensive care unit , transplantation , surgery , mechanical ventilation , cohort , cardiology , retrospective cohort study , myocardial infarction
Coronary artery disease (CAD) is common in lung transplant candidates and may require revascularization before or at the time of their transplant. We reviewed the survival of lung transplant recipients with CAD requiring surgical intervention (CAD-coronary artery bypass grafting [CABG]) and those who did not (CAD-NoCABG) at the time of transplant, compared to a cohort with no CAD (NoCAD).